In the United States, around 40 million people have substance problems—more individuals than have cancer, diabetes or heart problems. Although substance use disorders are treatable, many people don’t receive the help they need. Stigma, a lack of drug development progress and insufficiently trained medical professionals all hinder individuals with addiction from getting proper treatment.
What is the neuroscience of addiction, and what is its impact on individuals, families and communities? What is the current state of therapeutics for substance use disorders?
Join Kristine Yoon, a pharmacology graduate student, and an expert panel to explore these questions and more during the next Lab-to-Table Conversation from the Vanderbilt University School of Medicine Basic Sciences. The virtual event will be on Wednesday, Jan. 24, at 11:30 a.m. CT and will feature the following panelists:
- Erin Calipari, associate professor of pharmacology and director of the Vanderbilt Center for Addiction Research
- Craig Lindsley, executive director of the Warren Center for Neuroscience Drug Discovery and University Professor of Pharmacology, Biochemistry and Chemistry, who holds the William K. Warren, Jr. Chair in Medicine
- William (Bill) Stoops, University of Kentucky associate director for clinical research, substance use priority research area, and faculty affiliate of Center on Drug and Alcohol Research
- Jan Hoffman, behavioral health and health law reporter for The New York Times
